Evidence map›Paper›PMID 10954570›Full record

ArticleJournal of virology2000

Membrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera.

J B Bowzard, R J Visalli, C B Wilson, J S Loomis, E M Callahan, R J Courtney, J W Wills

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. EHV-1: A Constant Threat to the Horse Industry.Frontiers in microbiology · 2019
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

J B BowzardDepartment of Microbiology and Immunology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA.
R J Visalli
C B Wilson
J S Loomis
E M Callahan
R J Courtney
J W Wills
Pennsylvania State University · US

Funding

VIRUSES AND CANCERT32CA060395 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MEYERS, CRAIG M · 1994 to 2021
$4.3M
Molecular Analysis of the Retroviral Budding MechanismR37CA047482 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI WILLS, JOHN W. · 2001 to 2005
$2.4M
STUDIES OF PURIFIED HERPES SIMPLEX VIRUS GLYCOPROTEINSR01CA042460 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI COURTNEY, RICHARD J · 1985 to 2005
$1.7M
GAG DOMAINS REQUIRED FOR RETROVIRUS ASSEMBLYR01CA047482 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI WILLS, JOHN W. · 1991 to 2000
$396k
ANALYSIS OF RETROVIRUS ASSEMBLY BY IN VITRO MUTAGENESISR29CA047482 · NCI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI WILLS, JOHN W. · 1987 to 1990
–
NCI NIH HHS CA42460NCI NIH HHS CA47482NCI NIH HHS CA60395NCI NIH HHS R01 CA042460NCI NIH HHS R01 CA047482NCI NIH HHS R37 CA047482NCI NIH HHS T32 CA060395
6 · The paper itself

Abstract

The retroviral Gag protein is capable of directing the production and release of virus-like particles in the absence of all other viral components. Budding normally occurs after Gag is transported to the plasma membrane by its membrane-targeting and -binding (M) domain. In the Rous sarcoma virus (RSV) Gag protein, the M domain is contained within the first 86 amino acids. When M is deleted, membrane association and budding fail to occur. Budding is restored when M is replaced with foreign membrane-binding sequences, such as that of the Src oncoprotein. Moreover, the RSV M domain is capable of targeting heterologous proteins to the plasma membrane. Although the solution structure of the RSV M domain has been determined, the mechanism by which M specifically targets Gag to the plasma membrane rather than to one or more of the large number of internal membrane surfaces (e.g., the Golgi apparatus, endoplasmic reticulum, and nuclear, mitochondrial, or lysosomal membranes) is unknown. To further investigate the requirements for targeting proteins to discrete cellular locations, we have replaced the M domain of RSV with the product of the unique long region 11 (U(L)11) gene of herpes simplex virus type 1. This 96-amino-acid myristylated protein is thought to be involved in virion transport and envelopment at internal membrane sites. When the first 100 amino acids of RSV Gag (including the M domain) were replaced by the entire UL11 sequence, the chimeric protein localized at and budded into the Golgi apparatus rather than being targeted to the plasma membrane. Myristate was found to be required for this specific targeting, as were the first 49 amino acids of UL11, which contain an acidic cluster motif. In addition to shedding new light on UL11, these experiments demonstrate that RSV Gag can be directed to internal cellular membranes and suggest that regions outside of the M domain do not contain a dominant plasma membrane-targeting motif.

Indexed as

Virus ReplicationAmino Acid SequenceAnimalsAvian Sarcoma VirusesCell MembraneCOS CellsFluorescent Antibody TechniqueGene Products, gagGolgi ApparatusHerpesvirus 1, HumanIntracellular MembranesMicroscopy, ConfocalMicroscopy, ElectronMolecular Sequence DataMyristic AcidProtein Structure, TertiaryGene Products, gagMyristic AcidRecombinant Fusion ProteinsUL11 protein, herpesviridaeViral Structural Proteins

Identifiers

PMID10954570
PMCPMC116380
OpenAlexW2126984975

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.